News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AMAG Pharmaceuticals, Inc. (AMAG) Reports Third Quarter and Nine Month 2013 Financial Results


10/23/2013 9:34:22 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WALTHAM, Mass., Oct. 23, 2013 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG), a specialty pharmaceutical company, today reported unaudited consolidated financial results for the third quarter and nine months ended September 30, 2013. Total revenues for the third quarter of 2013 were $21.6 million, of which $19.3 million were U.S. net FerahemeĀ® (ferumoxytol) sales, the highest Feraheme quarterly sales since launch in 2009. AMAG generated positive cash flows during the quarter and ended the third quarter with $213.5 million in cash and investments.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES